New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors
- PMID: 23407849
- PMCID: PMC3558130
New Variations in the Promoter Regions of Human DOCK4 and RAP1A Genes, and Coding Regions of RAP1A in Sporadic Breast Tumors
Abstract
Breast cancer is the most common cancer among women in developed countries. The prevalence of the disease is increasing in the world. Its annual incidence among Iranian women is about 7000 cases. RAP1A, a tumor suppressor gene, is located at 1p13.3 and plays an important role in the cellular adhesion pathway and is involved in the pathogenesis of breast cancer. The DOCK4 gene, which is located at 7q31.1, specifically activates RAP1A gene. In the present study, DNA samples from 64 cases of sporadic breast tumors (referred to Mehrad Hospital in Tehran) were screened using PCR-SSCP method and the number of observed variations compared with the control group (100 normal women). Mutation detection for coding exons of RAP1A gene and the 500 bp upstream of transcription initiation site as promoters of both DOCK4 and RAP1A were carried out and compared with the control group. The promoter region of DOCK4 showed a heterozygous mutation with G>A transition at nucleotide -303 in a fibroadenoma case. With regard to RAP1A we found a heterozygous mutation, G>A transition in an adenoid cystic carcinoma case, and another heterozygous mutation, G>T transversion in an intraductal papilloma case both at nucleotide +45. A homozygous variation, T>A transversion was also found at nucleotide +29 of a fibroadenoma case. The differences in the frequency of variations mentioned above were not statistically significant. However Fisher's exact showed significant difference for T>A transversion. Although, the higher frequency of these mutations and variations may be related to the disease, a larger sample size is needed for the confirmation of our findings.
Keywords: DOCK4; Loss of heterozygosity (LOH); PCR-SSCP; RAP1A; Sporadic breast tumor.
Figures



Similar articles
-
Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.Carcinogenesis. 1999 Sep;20(9):1689-96. doi: 10.1093/carcin/20.9.1689. Carcinogenesis. 1999. PMID: 10469612
-
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8. Breast Cancer Res Treat. 2004. PMID: 15564800
-
Mutation analysis of the DBC2 gene in sporadic and familial breast cancer.Acta Oncol. 2007;46(6):770-2. doi: 10.1080/02841860601047752. Acta Oncol. 2007. PMID: 17653899
-
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.Adv Exp Med Biol. 1997;407:41-53. doi: 10.1007/978-1-4899-1813-0_7. Adv Exp Med Biol. 1997. PMID: 9321930 Review.
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
Cited by
-
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.J Pathol. 2019 Mar;247(3):381-391. doi: 10.1002/path.5197. Epub 2019 Jan 25. J Pathol. 2019. PMID: 30426503 Free PMC article.
-
DOCK4 deletion at 7q31.1 in a de novo acute myeloid leukemia with a normal karyotype.Cell Oncol (Dordr). 2013 Oct;36(5):395-403. doi: 10.1007/s13402-013-0145-5. Epub 2013 Aug 27. Cell Oncol (Dordr). 2013. PMID: 23979775
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin. 2005;55(2):74–108. - PubMed
-
- Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383–391. - PubMed
-
- Hedau S, Jain N, Husain SA, Mandal AK, Ray G, Shahid M, et al. Novel germ line mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res Treat. 2004;88(2):177–186. - PubMed
-
- Osborne C, Wilson P, Tripathy D. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist. 2004;9(4):361–377. - PubMed
-
- Mitchell EL, Santibanez-Koref MF. 1p13 is the most frequently involved band in structural chromosomal rearrangements in human breast cancer. Genes Chromosomes Cancer. 1990;2(4):278–289. - PubMed
LinkOut - more resources
Full Text Sources